Efficacy of SMART Stent Placement for Salvage Angioplasty in Hemodialysis Patients with Recurrent Vascular Access Stenosis

Vascular access stenosis is a major complication in hemodialysis patients. We prospectively observed 50 patients in whom 50 nitinol shape-memory alloy-recoverable technology (SMART) stents were used as salvage therapy for recurrent peripheral venous stenosis. Twenty-five stents each were deployed in...

Full description

Saved in:
Bibliographic Details
Main Authors: Shingo Hatakeyama, Terumasa Toikawa, Akiko Okamoto, Hayato Yamamoto, Kengo Imanishi, Teppei Okamoto, Noriko Tokui, Yuichiro Suzuki, Naoki Sugiyama, Atsushi Imai, Yasuhiro Hashimoto, Shigemasa Kudo, Takahiro Yoneyama, Takuya Koie, Noritaka Kamimura, Hisao Saitoh, Tomihisa Funyu, Chikara Ohyama
Format: Article
Language:English
Published: Wiley 2011-01-01
Series:International Journal of Nephrology
Online Access:http://dx.doi.org/10.4061/2011/464735
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832551152446603264
author Shingo Hatakeyama
Terumasa Toikawa
Akiko Okamoto
Hayato Yamamoto
Kengo Imanishi
Teppei Okamoto
Noriko Tokui
Yuichiro Suzuki
Naoki Sugiyama
Atsushi Imai
Yasuhiro Hashimoto
Shigemasa Kudo
Takahiro Yoneyama
Takuya Koie
Noritaka Kamimura
Hisao Saitoh
Tomihisa Funyu
Chikara Ohyama
author_facet Shingo Hatakeyama
Terumasa Toikawa
Akiko Okamoto
Hayato Yamamoto
Kengo Imanishi
Teppei Okamoto
Noriko Tokui
Yuichiro Suzuki
Naoki Sugiyama
Atsushi Imai
Yasuhiro Hashimoto
Shigemasa Kudo
Takahiro Yoneyama
Takuya Koie
Noritaka Kamimura
Hisao Saitoh
Tomihisa Funyu
Chikara Ohyama
author_sort Shingo Hatakeyama
collection DOAJ
description Vascular access stenosis is a major complication in hemodialysis patients. We prospectively observed 50 patients in whom 50 nitinol shape-memory alloy-recoverable technology (SMART) stents were used as salvage therapy for recurrent peripheral venous stenosis. Twenty-five stents each were deployed in native arteriovenous fistula (AVF) and synthetic arteriovenous polyurethane graft (AVG) cases. Vascular access patency rates were calculated by Kaplan-Meier analysis. The primary patency rates in AVF versus AVG at 3, 6, and 12 months were 80.3% versus 75.6%, 64.9% versus 28.3%, and 32.3% versus 18.9%, respectively. The secondary patency rates in AVF versus AVG at 3, 6, and 12 months were 88.5% versus 75.5%, 82.6% versus 61.8%, and 74.4% versus 61.8%, respectively. Although there were no statistically significant difference in patency between AVF and AVG, AVG showed poor tendency in primary and secondary patency. The usefulness of SMART stents was limited in a short period of time in hemodialysis patients with recurrent vascular access stenosis.
format Article
id doaj-art-ddfbdfc03f394754b18312b38ab4993c
institution Kabale University
issn 2090-214X
2090-2158
language English
publishDate 2011-01-01
publisher Wiley
record_format Article
series International Journal of Nephrology
spelling doaj-art-ddfbdfc03f394754b18312b38ab4993c2025-02-03T06:04:59ZengWileyInternational Journal of Nephrology2090-214X2090-21582011-01-01201110.4061/2011/464735464735Efficacy of SMART Stent Placement for Salvage Angioplasty in Hemodialysis Patients with Recurrent Vascular Access StenosisShingo Hatakeyama0Terumasa Toikawa1Akiko Okamoto2Hayato Yamamoto3Kengo Imanishi4Teppei Okamoto5Noriko Tokui6Yuichiro Suzuki7Naoki Sugiyama8Atsushi Imai9Yasuhiro Hashimoto10Shigemasa Kudo11Takahiro Yoneyama12Takuya Koie13Noritaka Kamimura14Hisao Saitoh15Tomihisa Funyu16Chikara Ohyama17Department of Advanced Transplant and Regenerative Medicine, Hirosaki University Graduate School of Medicine, Hirosaki 036-8562, JapanDepartment of Radiological Technology, Oyokyo Kidney Research Institute, Hirosaki 036-8243, JapanDepartment of Urology, Oyokyo Kidney Research Institute, Hirosaki 036-8243, JapanDepartment of Urology, Hirosaki University Graduate School of Medicine, Hirosaki 036-8562, JapanDepartment of Urology, Oyokyo Kidney Research Institute, Hirosaki 036-8243, JapanDepartment of Urology, Hirosaki University Graduate School of Medicine, Hirosaki 036-8562, JapanDepartment of Urology, Hirosaki University Graduate School of Medicine, Hirosaki 036-8562, JapanDepartment of Urology, Hirosaki University Graduate School of Medicine, Hirosaki 036-8562, JapanDepartment of Urology, Hirosaki University Graduate School of Medicine, Hirosaki 036-8562, JapanDepartment of Urology, Hirosaki University Graduate School of Medicine, Hirosaki 036-8562, JapanDepartment of Urology, Oyokyo Kidney Research Institute, Hirosaki 036-8243, JapanDepartment of Urology, Hirosaki University Graduate School of Medicine, Hirosaki 036-8562, JapanDepartment of Urology, Hirosaki University Graduate School of Medicine, Hirosaki 036-8562, JapanDepartment of Urology, Hirosaki University Graduate School of Medicine, Hirosaki 036-8562, JapanDepartment of Urology, Hirosaki University Graduate School of Medicine, Hirosaki 036-8562, JapanDepartment of Urology, Oyokyo Kidney Research Institute, Hirosaki 036-8243, JapanDepartment of Urology, Oyokyo Kidney Research Institute, Hirosaki 036-8243, JapanDepartment of Advanced Transplant and Regenerative Medicine, Hirosaki University Graduate School of Medicine, Hirosaki 036-8562, JapanVascular access stenosis is a major complication in hemodialysis patients. We prospectively observed 50 patients in whom 50 nitinol shape-memory alloy-recoverable technology (SMART) stents were used as salvage therapy for recurrent peripheral venous stenosis. Twenty-five stents each were deployed in native arteriovenous fistula (AVF) and synthetic arteriovenous polyurethane graft (AVG) cases. Vascular access patency rates were calculated by Kaplan-Meier analysis. The primary patency rates in AVF versus AVG at 3, 6, and 12 months were 80.3% versus 75.6%, 64.9% versus 28.3%, and 32.3% versus 18.9%, respectively. The secondary patency rates in AVF versus AVG at 3, 6, and 12 months were 88.5% versus 75.5%, 82.6% versus 61.8%, and 74.4% versus 61.8%, respectively. Although there were no statistically significant difference in patency between AVF and AVG, AVG showed poor tendency in primary and secondary patency. The usefulness of SMART stents was limited in a short period of time in hemodialysis patients with recurrent vascular access stenosis.http://dx.doi.org/10.4061/2011/464735
spellingShingle Shingo Hatakeyama
Terumasa Toikawa
Akiko Okamoto
Hayato Yamamoto
Kengo Imanishi
Teppei Okamoto
Noriko Tokui
Yuichiro Suzuki
Naoki Sugiyama
Atsushi Imai
Yasuhiro Hashimoto
Shigemasa Kudo
Takahiro Yoneyama
Takuya Koie
Noritaka Kamimura
Hisao Saitoh
Tomihisa Funyu
Chikara Ohyama
Efficacy of SMART Stent Placement for Salvage Angioplasty in Hemodialysis Patients with Recurrent Vascular Access Stenosis
International Journal of Nephrology
title Efficacy of SMART Stent Placement for Salvage Angioplasty in Hemodialysis Patients with Recurrent Vascular Access Stenosis
title_full Efficacy of SMART Stent Placement for Salvage Angioplasty in Hemodialysis Patients with Recurrent Vascular Access Stenosis
title_fullStr Efficacy of SMART Stent Placement for Salvage Angioplasty in Hemodialysis Patients with Recurrent Vascular Access Stenosis
title_full_unstemmed Efficacy of SMART Stent Placement for Salvage Angioplasty in Hemodialysis Patients with Recurrent Vascular Access Stenosis
title_short Efficacy of SMART Stent Placement for Salvage Angioplasty in Hemodialysis Patients with Recurrent Vascular Access Stenosis
title_sort efficacy of smart stent placement for salvage angioplasty in hemodialysis patients with recurrent vascular access stenosis
url http://dx.doi.org/10.4061/2011/464735
work_keys_str_mv AT shingohatakeyama efficacyofsmartstentplacementforsalvageangioplastyinhemodialysispatientswithrecurrentvascularaccessstenosis
AT terumasatoikawa efficacyofsmartstentplacementforsalvageangioplastyinhemodialysispatientswithrecurrentvascularaccessstenosis
AT akikookamoto efficacyofsmartstentplacementforsalvageangioplastyinhemodialysispatientswithrecurrentvascularaccessstenosis
AT hayatoyamamoto efficacyofsmartstentplacementforsalvageangioplastyinhemodialysispatientswithrecurrentvascularaccessstenosis
AT kengoimanishi efficacyofsmartstentplacementforsalvageangioplastyinhemodialysispatientswithrecurrentvascularaccessstenosis
AT teppeiokamoto efficacyofsmartstentplacementforsalvageangioplastyinhemodialysispatientswithrecurrentvascularaccessstenosis
AT norikotokui efficacyofsmartstentplacementforsalvageangioplastyinhemodialysispatientswithrecurrentvascularaccessstenosis
AT yuichirosuzuki efficacyofsmartstentplacementforsalvageangioplastyinhemodialysispatientswithrecurrentvascularaccessstenosis
AT naokisugiyama efficacyofsmartstentplacementforsalvageangioplastyinhemodialysispatientswithrecurrentvascularaccessstenosis
AT atsushiimai efficacyofsmartstentplacementforsalvageangioplastyinhemodialysispatientswithrecurrentvascularaccessstenosis
AT yasuhirohashimoto efficacyofsmartstentplacementforsalvageangioplastyinhemodialysispatientswithrecurrentvascularaccessstenosis
AT shigemasakudo efficacyofsmartstentplacementforsalvageangioplastyinhemodialysispatientswithrecurrentvascularaccessstenosis
AT takahiroyoneyama efficacyofsmartstentplacementforsalvageangioplastyinhemodialysispatientswithrecurrentvascularaccessstenosis
AT takuyakoie efficacyofsmartstentplacementforsalvageangioplastyinhemodialysispatientswithrecurrentvascularaccessstenosis
AT noritakakamimura efficacyofsmartstentplacementforsalvageangioplastyinhemodialysispatientswithrecurrentvascularaccessstenosis
AT hisaosaitoh efficacyofsmartstentplacementforsalvageangioplastyinhemodialysispatientswithrecurrentvascularaccessstenosis
AT tomihisafunyu efficacyofsmartstentplacementforsalvageangioplastyinhemodialysispatientswithrecurrentvascularaccessstenosis
AT chikaraohyama efficacyofsmartstentplacementforsalvageangioplastyinhemodialysispatientswithrecurrentvascularaccessstenosis